|Global Healthcare Industry Outlook, 2018|
|Value-based Care Will Continue to Drive Growth Opportunities for Emerging Technologies as They Move Out form Pilot Testing into Production Environments|
In this research deliverable, Frost & Sullivan provides bold perspectives and predictions for the global healthcare industry in 2018. The markets covered include pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT. The analysis captures sectoral and regional trends and provides predictions for the upcoming year as organizations. This study provides guidance on where to find the greatest opportunities for expansion. Despite political uncertainties and cost pressures, the global healthcare industry will register a stable growth rate of 4.82% during 2018. With high spending on healthcare, prices of medical devices, consumables and drugs will continue to decline in the developed markets of the US and Western Europe. This would provide the impetus to change the paradigms of product development and geographic rollouts across high growth, emerging healthcare markets, especially the Asia-Pacific region.
Click image to view it in full size